Form D · Other Technology
Arkea Bio Corp.
Charlestown, MA · CIK 0002004801
Offering snapshot reported Oct 9, 2026 · SEC filing
- Reported sold
- $15M Offering amount: $33M
- Investors reported
- 2 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Sep 28, 2026 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Oct 9, 2026 | Initial | $14,999,995 | No comparison | 2 | SEC filing |
| Oct 14, 2025 | Initial | $6,999,999 | No comparison | 2 | SEC filing |
| Dec 20, 2023 | Initial | Yet to sell | No comparison | 0 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-600629
Source: Form D, filed Oct 9, 2026. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Matthew Dunn | Executive |
| Wayne Mc Nee | Director |
| Chris Rivest | Director |
| Zachariah Serber | Executive |
| Ginja Silva | Executive |
| Colin South | Director, Executive |
| Frank Wooten | Director, Executive |
Issuer details
Industry: Other Technology (See others in industry)
Address:
500 Rutherford Ave Ste. 302
Charlestown, MA, 02129
Charlestown, MA, 02129